The global PTA balloon catheter market size is expected to reach USD 4.63 billion by 2030, registering a CAGR of 8.32% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of peripheral artery disorder and the rising number of Percutaneous Coronary Intervention (PCI) procedures in developing countries are key factors driving the market.
The adoption of a sedentary lifestyle by most of the population has increased the prevalence rate of various types of cardiovascular diseases worldwide. An increase in the number of cases of cardiovascular diseases across the globe is expected to boost the adoption of various procedures-such as cardiac catheterizations, angioplasty, and Percutaneous Coronary Intervention (PCI)-to treat such conditions, wherein PTA balloon catheters are among the essential requirements.
The COVID-19 pandemic resulted in a decline in the number of patient encounters, leading to a reduction in the demand for surgical procedures, thereby impacting the industry growth. According to Elsevier, the number of coronary angioplasty surgeries was 11.2% in 2020, which is lower than the previously reported data. According to the National Library of Medicine, the U.S. witnessed a 52.7% decline in adult cardiac surgeries in 2020. In the later phase, as the restrictions were lifted in several countries, the volume of cardiac and peripheral surgical procedures increased. This is expected to increase the demand for angioplasty surgical devices such as PTA balloon catheters.
Request a free sample copy or view the report summary: PTA Balloon Catheter Market Report
North America market dominated with a share of 47.95% in 2023. This can be attributed to the higher product availability, high demand for surgical procedures, and better awareness in the region
Asia Pacific is expected to exhibit the fastest growth rate during the forecast period due to government initiatives and increasing incidence of target disorders
Supportive government regulations to commercialize medical devices in Latin America are expected to impel industry growth. For instance, most Latin American countries only require the U.S. FDA or CE mark approval for filing marketing approvals
Incorporation of the latest health technologies, partnerships and collaborations, product expansion, and mergers & acquisitions are some of the strategies being adopted by key players to gain a competitive edge in the market. For instance, in February 2022, Boston Scientific Corporation acquired Baylis Medical Company, Inc., a medical device company primarily providing solutions to support catheter-based left heart procedures
The shortage of cardiac surgeons worldwide is a big concern. Low-income countries are facing this issue more severely. For instance, North Africa has only one surgeon per 1.1 million people. This is resulting in restricting the number of surgeries that could be performed, hindering industry growth
Grand View Research has segmented the global PTA balloon catheter market on the basis of on material type, application, end-use, and region:
PTA Balloon Catheter Material Type Outlook (Revenue, USD Million, 2018 - 2030)
Polyurethane
Nylon
Others
PTA Balloon Catheter Application Outlook (Revenue, USD Million, 2018 - 2030)
Peripheral Artery Disease
Coronary Artery Disease
PTA Balloon Catheter End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Ambulatory Surgical Centers
Others
PTA Balloon Catheter Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in PTA Balloon Catheter Market
Medtronic
Tuermo Corporation
Cardinal Health
Boston Scientific Corporation.
Natec Medical
Cook Medical
Biotronik
Surmodics, Inc.
Andratec
"The quality of research they have done for us has been excellent..."